*COVID-19/epidemiology/prevention & control

Català, M., Mercadé-Besora, N., Kolde, R., Trinh, N. T. H., Roel, E., Burn, E., et al. (2024). The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia. Lancet Respir Med, 12, 225-236. http://doi.org/10.1016/s2213-2600(23)00414-9

View

Burn, E., Li, X., Delmestri, A., Jones, N., Duarte-Salles, T., Reyes, C., et al. (2022). Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in the United Kingdom. Nat Commun, 13, 7167. http://doi.org/10.1038/s41467-022-34668-w

View

Burn, E., Li, X., Kostka, K., Stewart, H. M., Reich, C., Seager, S., et al. (2022). Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries. Pharmacoepidemiol Drug Saf, 31, 495-510. http://doi.org/10.1002/pds.5419

View